Moreover, the concurrent chemoradiotherapy (CCRT) followed by programmed death 1 ligand (PD-L1) inhibitor treatment is the standard strategy for unresectable stage III lung cancer patients (7). The gene discussed is CD274; the disease is lung carcinoma.